Atomera Provides First Quarter 2025 Results
Rhea-AI Summary
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, reported its Q1 2025 financial results. The company recorded a net loss of $5.2 million ($0.17 per share), compared to a loss of $4.8 million ($0.19 per share) in Q1 2024. Cash position stood at $24.1 million as of March 31, 2025, down from $26.8 million at the end of 2024.
Key developments include signing a strategic marketing agreement with a leading chip fabrication equipment vendor, expanding engagements with ST Microelectronics and RFSOI customers, and building first-ever MST-enabled GaN devices at Sandia. The company believes its new equipment vendor collaboration will drive license revenues while benefiting both parties.
Positive
- Strategic marketing agreement secured with leading chip fabrication equipment vendor
- Expansion of engagements with ST Microelectronics and RFSOI customers to new applications
- Achievement of first MST-enabled GaN devices at Sandia
Negative
- Net loss increased to $5.2 million in Q1 2025 from $4.8 million in Q1 2024
- Cash position decreased to $24.1 million from $26.8 million in the previous quarter
- Adjusted EBITDA loss widened to $4.4 million from $4.0 million year-over-year
Insights
Atomera advances MST technology through equipment vendor partnership, expanded ST Micro applications, and first GaN devices with Sandia.
Atomera's Q1 announcement highlights strategic advancement for their MST semiconductor enhancement technology. The collaboration with an unnamed leading capital equipment company represents a potential inflection point. In semiconductor manufacturing, equipment vendor partnerships can significantly accelerate technology adoption by integrating new processes into established fabrication systems that chipmakers already trust and use.
The company reports expanded engagements with ST Microelectronics and their RFSOI customers to new applications. ST Micro's position as a major global semiconductor manufacturer makes their continued interest particularly noteworthy, as their product portfolio spans automotive, industrial, personal electronics, and communications infrastructure markets.
Perhaps most technically significant is Atomera's development of first MST-enabled GaN (Gallium Nitride) devices at Sandia National Laboratories, with electrical testing now underway. This expansion beyond silicon demonstrates MST's potential versatility. GaN technology is increasingly critical for high-power, high-frequency applications including power conversion, RF amplification, and emerging applications where silicon reaches physical limitations.
These developments collectively suggest Atomera is executing on multiple fronts to build technology credibility and create potential commercialization pathways, though as typical in semiconductor materials development, the progression from technical validation to commercial revenue often requires multiple years of qualification and integration work.
Atomera's widening losses and cash burn continue while pre-revenue development progresses; strategic partnerships may accelerate commercialization timeline.
Atomera's Q1 2025 financial results demonstrate the company's ongoing pre-revenue investment phase. The company reported a net loss of
The press release notably lacks mention of any revenue figures, suggesting limited or no revenue generation in the quarter as the company continues to focus on technology development and partnership building.
Atomera's cash position decreased by
The strategic marketing agreement with a capital equipment vendor and expanded customer engagements represent potential catalysts for future commercialization, though the press release provides no specific projections or timelines. For semiconductor materials companies like Atomera, the path from technology development to meaningful licensing revenue typically requires sustained investment through extended qualification cycles and integration into customer manufacturing processes.
With 30.7 million shares outstanding as of March 31, 2025, investors should monitor both technological progress and financial metrics in coming quarters for signs of commercial traction that could eventually translate to licensing revenue.
LOS GATOS, CA / ACCESS Newswire / May 6, 2025 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2025.
Recent Company Highlights
Signed strategic marketing agreement with leading chip fabrication equipment vendor
Expanded engagements at ST Microelectronics and RFSOI customers to new applications
Built first ever MST-enabled GaN devices at Sandia and began electrical testing
Management Commentary
"Our recently announced collaboration with a leading capital equipment company will strengthen Atomera's deal execution on many different levels. We believe the collaboration will drive our license revenues while growing our partner's capital equipment tool sales giving incentives for both of us to make it a success," said Scott Bibaud, President and CEO. "Our expansion to new application areas with ST and our fabless RF licensee are evidence of the growing opportunities available for MST as we deepen our relationships with our lead customers."
Financial Results
The Company incurred a net loss of (
The Company had
The total number of shares outstanding was 30.7 million as of March 31, 2025.
First Quarter 2025 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, May 6, 2025
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics does not proceed with qualification of MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and knowhow and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on March 4, 2025. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow -
Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)
March 31, | December 31, | |||||||
2025 | 2024 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 24,123 | $ | 25,778 | ||||
Short-term investments | - | 995 | ||||||
Unbilled contracts receivable | - | 6 | ||||||
Interest receivable | 81 | 73 | ||||||
Prepaid expenses and other current assets | 335 | 240 | ||||||
Total current assets | 2,4539 | 27,092 | ||||||
Property and equipment, net | 52 | 59 | ||||||
Long-term prepaid maintenance and supplies | 91 | 91 | ||||||
Security deposit | 14 | 14 | ||||||
Operating lease right-of-use asset | 218 | 280 | ||||||
Financing lease right-of-use-asset | 1,338 | 1,588 | ||||||
Total assets | $ | 26,252 | $ | 29,124 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 761 | $ | 492 | ||||
Accrued expenses | 195 | 239 | ||||||
Accrued payroll related expenses | 402 | 1,328 | ||||||
Current operating lease liability | 184 | 260 | ||||||
Current financing lease liability | 1,314 | 1,253 | ||||||
Deferred Revenue | - | 4 | ||||||
Total current liabilities | 2,856 | 3,576 | ||||||
Long-term operating lease liability | - | 22 | ||||||
Long-term financing lease liability | 113 | 449 | ||||||
Total liabilities | 2,969 | 4,047 | ||||||
Commitments and contingencies | - | - | ||||||
Stockholders' equity: | ||||||||
Preferred stock | - | - | ||||||
Common stock: | 31 | 31 | ||||||
Additional paid in capital | 249,981 | 246,565 | ||||||
Other comprehensive income (loss) | - | 1 | ||||||
Accumulated deficit | (226,729 | ) | (221,520 | ) | ||||
Total stockholders' equity | 23,283 | 25,077 | ||||||
Total liabilities and stockholders' equity | $ | 26,252 | $ | 29,124 | ||||
Atomera Incorporated
Condensed Statements of Operations
(in thousands, except per share data)
Three Months Ended | ||||||||||||
March 31, | December 31, | March 31, | ||||||||||
2025 | 2024 | 2024 | ||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | ||||||||||
Revenue | $ | 4 | $ | 23 | $ | 18 | ||||||
Cost of revenue | - | (13 | ) | (33 | ) | |||||||
Gross margin | 4 | 10 | (15 | ) | ||||||||
Operating expenses | ||||||||||||
Research and development | 3,255 | 2,823 | 2,858 | |||||||||
General and administrative | 2,088 | 1,811 | 1,811 | |||||||||
Selling and marketing | 124 | 248 | 350 | |||||||||
Total operating expenses | 5,467 | 4,882 | 5,019 | |||||||||
Loss from operations | (5,463 | ) | (4,872 | ) | (5,034 | ) | ||||||
Other income (expense) | ||||||||||||
Interest income | 270 | 213 | 205 | |||||||||
Accretion income | 6 | 26 | 46 | |||||||||
Interest Expense | (21 | ) | (25 | ) | (39 | ) | ||||||
Other income (expense), net | (1 | ) | 1 | - | ||||||||
Total other income (expense), net | 254 | 215 | 212 | |||||||||
Net loss | $ | (5,209 | ) | $ | (4,595 | ) | $ | (4,822 | ) | |||
Net loss per common share, basic and diluted | $ | (0.17 | ) | $ | (0.16 | ) | $ | (0.19 | ) | |||
Weighted average number of common shares outstanding, basic and diluted | 30,243 | 28,934 | 26,038 | |||||||||
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
Unaudited)
Three Months Ended | ||||||||||||
March 31, | December 31, | March 31, | ||||||||||
2025 | 2024 | 2024 | ||||||||||
Net loss (GAAP) | $ | (5,209 | ) | $ | (4,657 | ) | $ | (4,822 | ) | |||
Depreciation and amortization | 12 | 12 | 17 | |||||||||
Stock-based compensation | 1,009 | 949 | 1,024 | |||||||||
Interest income | (270 | ) | (213 | ) | (205 | ) | ||||||
Accretion income | (6 | ) | (26 | ) | (46 | ) | ||||||
Interest expense | 21 | 25 | 39 | |||||||||
Other (income) expense, net | 1 | (1 | ) | - | ||||||||
Net loss non-GAAP EBITDA | $ | (4,442 | ) | $ | (3,911 | ) | $ | (3,993 | ) | |||
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com
SOURCE: Atomera, Inc
View the original press release on ACCESS Newswire
FAQ
What were Atomera's (ATOM) financial results for Q1 2025?
What major partnerships did Atomera (ATOM) announce in Q1 2025?
How much cash does Atomera (ATOM) have as of Q1 2025?
What technical milestone did Atomera (ATOM) achieve at Sandia in Q1 2025?
